Association Between Uric Acid and Acute Coronary Syndrome

Sponsor
Sohag University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05770323
Collaborator
(none)
150
12

Study Details

Study Description

Brief Summary

The aim of the study is to acess the association between admission serum uric acid level and in_hospital outcomes in patients with acute coronary syndromes

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Uric acid level

Detailed Description

Prospective study

  1. To acess patients with acute coronary syndrome including one of (typical Chest pain _ECGchanges _elevated cardic enzyme)

  2. the complication occur in patients with hyperurecemia and those with normal uric acid

Study Design

Study Type:
Observational
Anticipated Enrollment :
150 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
The Association Between Serum Uric Acid Level and Acute Coronary Syndrome in_hospital Outcomes
Anticipated Study Start Date :
Mar 22, 2023
Anticipated Primary Completion Date :
Feb 22, 2024
Anticipated Study Completion Date :
Mar 22, 2024

Arms and Interventions

Arm Intervention/Treatment
Patients with normal uric acid levels

Patient with uric acid level (2.5_6)for femal and (3_7)for males

Diagnostic Test: Uric acid level
Uric acid will be measured for all Patients with acute coronary syndrome and result will be analysed

Patients with elevated uric acid level (hyperurecemia)

Uric acid level more than 7 for males and more than 6 for female

Diagnostic Test: Uric acid level
Uric acid will be measured for all Patients with acute coronary syndrome and result will be analysed

Outcome Measures

Primary Outcome Measures

  1. Association between serum uric acid level and acute coronary syndrome in hospital outcomes [From the day of admission and 30 days post discharge]

    Comparision between Patient with hyperurecemia and those with normal uric acid level

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:

all patients with acute coronary syndrome with one of the Following

  • Typical Chest pain

  • ECG changes

  • Elevated cardiac enzyme

Exclusion Criteria:
  • patients aged less than 18 years

  • patients with gout

  • patients with treated with diuretics

  • Patient with CKD

  • Patient with chronic haemolytic anemia

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Sohag University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Hadeer Hassan Abdelaty, Resident doctor at sohag University, Sohag University
ClinicalTrials.gov Identifier:
NCT05770323
Other Study ID Numbers:
  • Uric acid in ACSs
First Posted:
Mar 15, 2023
Last Update Posted:
Mar 15, 2023
Last Verified:
Mar 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 15, 2023